CASE STUDY | VIDEO

Biomarkers of Response for Clinical Trials

Welcome to the eighth in our series of case studies showcasing Metabolon clients’ achievements in discovery, preclinical, and clinical research.

Here, our client developed a patient-friendly way to show the efficacy of potential therapies for a severe form of liver inflammation – nonalcoholic steatohepatitis (NASH) – which has no FDA-approved treatments. This group of 22 potential blood biomarkers could replace the need for costly imaging or invasive liver biopsies in clinical trials for this disease.

    Contact Us

    Talk with an expert

    Request a quote for our services or more information on sample types and handling procedures, need a letter of support, or simply have questions about how metabolomics can advance your research.

    Corporate Headquarters

    617 Davis Drive, Suite 100
    Morrisville, NC 27560

    Mailing Address:
    P.O. Box 110407
    Research Triangle Park, NC 27709

    +1 (919) 572-1711

    +1 (919) 572-1721

    International Headquarters

    Metabolon GmbH

    Zeppelinstraße 3
    85399 Hallbergmoos
    Germany

    +49 89 99017752